Percutaneous aortic valve replacement: Overview and suggestions for anesthestic management

  • Heinze H
  • Sier H
  • Schäfer U
 et al. 
  • 22


    Mendeley users who have this article in their library.
  • 8


    Citations of this article.


Transcutaneous aortic valve replacement (AVR) is increasingly used for high-risk patients with severe aortic stenosis, who have high operative mortality for surgical placement during cardiopulmonary bypass (CPB). Retrograde transfemoral AVR is usually performed during sedation, whereas antegrade transapical AVR is done with general anesthesia. Both procedures can be carried out without CPB. Extended hemodynamic monitoring, including pulmonary artery catheterization and transesophageal echocardiography, may be useful. Transfemoral AVR requires placement of a transvenous right ventricular pacing lead. Typical complications include local bleeding, obstruction of the coronary ostia, and neurological insult due to embolization of sclerotic material. Aortic regurgitation due to paravalvular leakage or inadequate device expansion also may occur. Renal function may deteriorate on excessive application of contrast medium. Atrioventricular blocks may occur later rather than after conventional AVR which tend to occur immediately. © 2010 Elsevier Inc. All rights reserved.

Author-supplied keywords

  • Anesthesia
  • Aortic valve replacement
  • Atrioventricular block
  • Cardiac
  • Transcutaneous

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Hermann Heinze

  • Holger Sier

  • Ulrich Schäfer

  • Matthias Heringlake

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free